|Articles|August 1, 2009
- BioPharm International-08-01-2009
- Volume 22
- Issue 8
BioPharm International, August 2009 (PDF)
Pfizer Tackles Lean and Six Sigma
Advertisement
Articles in this issue
over 16 years ago
Use of Change-Point Analysis for Process Monitoring and Controlover 16 years ago
Analytical Tools for Process and Product Characterizationover 16 years ago
Laying the Foundationover 16 years ago
Waiting for Godot: Will Venture Funding Return?over 16 years ago
Health Reform Challenges Biotech Industryover 16 years ago
Avoiding the Regulatory Catch 22Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
